<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>miR-195, one of the miR-16/15/195/424/497 family members, has been shown to play an important role in <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we assess miR-195 expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, which has not been investigated before, and its clinical significance including survival analysis </plain></SENT>
<SENT sid="2" pm="."><plain>The in vivo significance of expression of miR-16/15/195/424/497 in matched <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> was evaluated using a quantitative real-time RT-PCR </plain></SENT>
<SENT sid="3" pm="."><plain>Two <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines and 85 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and paired <z:mpath ids='MPATH_458'>normal</z:mpath> patient samples with detailed clinical follow-up information were selected </plain></SENT>
<SENT sid="4" pm="."><plain>The statistical significance of these markers for disease prognosis was evaluated using a two-tailed, paired Wilcoxon test </plain></SENT>
<SENT sid="5" pm="."><plain>A Kaplan-Meier survival curve was generated following a logrank test </plain></SENT>
<SENT sid="6" pm="."><plain>As a result, miR-424 was significantly over-expressed, while miR-15a, miR-15b, miR-16, and miR-195 were downregulated in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> compared with <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal samples (<z:hpo ids='HP_0000001'>all</z:hpo> P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>Reduced expression of miR-195 occurred more often in patients with lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and advanced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage (<z:hpo ids='HP_0000001'>all</z:hpo> P &lt; 0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>Kaplan-Meier survival analysis indicated that patients with reduced miR-195 had a poor overall survival (P &lt; 0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, the multivariate analysis showed that reduced expression of miR-195 was an independent predictor of overall survival </plain></SENT>
<SENT sid="10" pm="."><plain>Our data indicate the potential of miR-195 as a novel diagnostic or prognostic biomarker for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>